Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid tranquilization of acute aggression with typical antipsychotics
IRCT20090726002232N4Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of haloperidol, promethazine, Aminazin and trifluoperazine in agitation and Aggression (not a disease; see rationale) (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Velocity of onset effect of sedative injections, Duration of effect of sedative injections and 2 more. Started Sep 2018; status: completed.
02
Drugs
haloperidolpromethazineAminazintrifluoperazine
03
Conditions
agitationAggression (not a disease; see rationale)
Beyond the preview
Go deeper on IRCT20090726002232N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090726002232N4.